17 .alpha.-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
AssigneeMerck & Co., Inc.
InventorsGary H. Rasmusson, Glenn F. Reynolds
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck & Co., Inc.
InventorsGary H. Rasmusson, Glenn F. Reynolds
Estimating the term…
17.beta.-Acyl-4-aza-5.alpha.-androst-1-en-3-ones of the formula: ##STR1## wherein R is selected from hydrogen, methyl and ethyl and R.sup.2 is a monovalent radical selected from straight carbons, or monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or 1 or more halo (Cl or Br) substituents, aralkyl selected from benzyl and phenethyl and heterocyclic selected from 2- or 4-pyridyl, 2-pyrrolyl, 2-furyl or thiophenyl; and R', R" and R'" are each selected from hydrogen and methyl and pharmaceutical formulation of the above compounds are active as testosterone 5.alpha.-reductase inhibitors and thus are useful topically for treatment of acne, seborrhea, female hirsutism, and systemically in treatment of benign prostatic hypertrophy.
A compound of the formula:
Dependencies are inferred from the claim text.